外体非编码RNA的性别特异性失调驱动多发性骨髓瘤的进展
Samaneh Maleknia1, Sanam Rezaei Benam1, Greg Ahmann2
1Division of Hematology/Oncology, Department of Medicine, Indiana University, Indianapolis, IN, USA.
Blood cancer journal
|October 16, 2025
概括
在多发性髓瘤 (MM) 中发现了外体非编码RNA (ncRNA) 的性别特异性差异. 这一发现是开发针对男性和女性患者量身定制的个性化疗法的关键,改善了治疗结果.
科学领域:
- 生物化学 生物化学
- 遗传学 是一个遗传学.
- 在瘤学瘤学.
背景情况:
- 多发性髓瘤 (MM) 涉及骨髓中的血细胞增殖.
- 在MM的性别差异背后的分子机制尚未完全理解.
- 了解这些差异对于个性化治疗策略至关重要.
研究的目的:
- 研究多发性骨髓瘤 (MM) 中外体非编码RNAs (ncRNAs) 的性别特异性失调.
- 在男性和女性MM患者和细胞系中识别不同的ncRNA表达特征.
- 探索ncRNAs在MM病变发生中的作用及其作为治疗点的潜力.
主要方法:
- 从男性和女性MM患者和MM细胞系的外体样本中深入分析失调的ncRNAs.
- 在各种临床环境中检查ncRNA表达 (新诊断,复发,进展等). ) 的情况.
- 途径丰富分析以确定受失调的ncRNAs影响的生物过程.
主要成果:
- 在MM中确定了明显的性别特异性ncRNA表达特征.
- 长非编码RNAs (lncRNAs) 和microRNAs (miRNAs) 在MM病变发生过程中发挥着关键作用.
- 外体提供增强的分辨率来检测转录基因变化,揭示性别特异性模式.
- 失调的ncRNAs影响涉及扩散,亡和基因调节的关键途径.
结论:
- 外体ncRNAs的性别特异性失调有助于MM进展和治疗反应的差异.
- 建立了一个具有性别特异性表达模式的ncRNA小组,影响mRNA调节和MM通路.
- 外体ncRNA分析对于设计MM中适合性别的治疗策略至关重要.
- 这项研究为多发性骨髓瘤治疗的个性化医疗方法铺平了道路.
更多相关视频
12:13Sequencing Small Non-coding RNA from Formalin-fixed Tissues and Serum-derived Exosomes from Castration-resistant Prostate Cancer Patients
Published on: November 19, 2019
7.2K
08:49Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
Published on: May 27, 2016
11.6K
相关概念视频
01:32RNA Splicing
60.3K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
60.3K
01:22MicroRNAs
23.9K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.9K
01:22MicroRNAs
3.8K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.8K
02:39lncRNA - Long Non-coding RNAs
9.8K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.8K
01:46Epigenetic Regulation
33.5K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.5K
01:36Overview of Exosomes
3.5K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.5K